6 articles
Kikunotsuyu Shuzo Co., Ltd. will release 'Kikunotsuyu akari DOUBLE FOUR', a new 44% alcohol by volume Awamori spirit, on April 24, 2026. The product is designed for cocktails and is based on the brand's 'akari' series, which uses vacuum distillation. A limited run of 440 bottles will be available at an open price, with online pre-orders starting April 14, 2026.
mudy on the 昨晩 announced the release of their 4th full album in Autumn 2026 and a 2-day 20th-anniversary concert event, "ALL SUPER MAXXXXX!!", to be held on November 28-29, 2026, at Nagoya Diamond Hall in Aichi. The album will feature previously released singles from 2025, including 'CLIMAXXX', 'reflection', and '戻らない', along with new tracks currently in production. The band, formed in 2006, is a Nagoya-based triple guitar instrumental band known for its post-rock/math-rock influences.
Nozomu Hayashi's new book, 'Enjoying Books: The Reason to Read Paper Books Now,' was released by Asahi Shimbun Publications on April 13, 2026. Hayashi addresses the declining paper publication market, which fell from approximately 2.6 trillion yen in 1996 to 964.7 billion yen in 2025. He also comments on the Japanese government's cabinet decision on April 7, 2026, to revise laws to officially recognize digital textbooks for free distribution in elementary and junior high schools. Hayashi advocates for the value of paper books, expressing concerns that digital textbooks could lead to the 'dumbing down' of society and hinder the appreciation of Japanese classical literature.
Hotlink launches "ULSSAS AD," a new SNS advertising method that converts ad spend into lasting UGC and branded search, addressing low follower display rates and information saturation on platforms like X.
ICHIBIKO is launching new Mother's Day limited sweets, including a special strawberry and berry cake, to express gratitude. These limited-edition treats offer a unique strawberry flavor and festive appearance, available for pre-order from April 15th.
Heroic has submitted an Investigational New Drug (IND) application to Taiwan's TFDA for its B10 L-BPA injection, aimed at pre-operative adjuvant therapy for locally advanced oral cancer. This study will evaluate Boron Neutron Capture Therapy (BNCT) as a novel treatment strategy.